Latrémouille-Viau D[au] - Search Results

Year	Number of Results
2008	1
2009	4
2010	6
2011	1
2012	3
2013	1
2014	3
2016	3
2017	3
2018	2
2019	3
2020	1
2021	5
2022	2
2023	0

1

Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States.

Blaiss MS, Meadows JA, Yu S, Robison DR, Hass SL, Norrett KE, Guerin A, Latremouille-Viau D, Tilles SA. Blaiss MS, et al. Among authors: latremouille viau d. J Manag Care Spec Pharm. 2021 Apr;27(4):516-527. doi: 10.18553/jmcp.2021.20389. Epub 2021 Jan 20. J Manag Care Spec Pharm. 2021. PMID: 33470880

2

Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency.

Latremouille-Viau D, Guerin A, Gagnon-Sanschagrin P, Dea K, Cohen BG, Joseph GJ. Latremouille-Viau D, et al. J Manag Care Spec Pharm. 2017 Feb;23(2):214-224. doi: 10.18553/jmcp.2017.23.2.214. J Manag Care Spec Pharm. 2017. PMID: 28125373

3

Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis.

Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P. Parfrey PS, et al. Among authors: latremouille viau d. Clin J Am Soc Nephrol. 2009 Apr;4(4):755-62. doi: 10.2215/CJN.02730608. Epub 2009 Apr 1. Clin J Am Soc Nephrol. 2009. PMID: 19339417 Free PMC article. Review.

4

Treatment patterns and outcomes in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.

Stein EM, Bonifacio G, Latremouille-Viau D, Shi S, Guerin A, Wu EQ, Sadek I, Cao X. Stein EM, et al. Among authors: latremouille viau d. Leuk Lymphoma. 2021 Jun;62(6):1411-1421. doi: 10.1080/10428194.2020.1869959. Epub 2021 Jan 11. Leuk Lymphoma. 2021. PMID: 33430673

5

Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals.

Meadows JA, Yu S, Hass SL, Guerin A, Latremouille-Viau D, Tilles SA. Meadows JA, et al. Among authors: latremouille viau d. Allergy Asthma Proc. 2021 Jul 1;42(4):333-342. doi: 10.2500/aap.2021.42.210047. Allergy Asthma Proc. 2021. PMID: 34187625

6

Chronic Myeloid Leukemia: Part II-Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective.

Atallah EL, Maegawa R, Latremouille-Viau D, Rossi C, Guérin A. Atallah EL, et al. Among authors: latremouille viau d. J Health Econ Outcomes Res. 2022 Aug 4;9(2):30-36. doi: 10.36469/001c.36976. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 35979529 Free PMC article.

7

Chronic Myeloid Leukemia: Part I-Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States.

Atallah EL, Maegawa R, Latremouille-Viau D, Rossi C, Guérin A, Wu EQ, Patwardhan P. Atallah EL, et al. Among authors: latremouille viau d. J Health Econ Outcomes Res. 2022 Aug 4;9(2):19-29. doi: 10.36469/001c.36975. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 35979528 Free PMC article.

8

Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates.

Atallah EL, Sadek I, Maegawa R, Cao X, Latremouille-Viau D, Pivneva I, Rossi C, Guerin A, Kota V. Atallah EL, et al. Among authors: latremouille viau d. Leuk Lymphoma. 2021 Jul;62(7):1730-1739. doi: 10.1080/10428194.2021.1885656. Epub 2021 Mar 1. Leuk Lymphoma. 2021. PMID: 33648418

9

Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.

Stein EM, Bonifacio G, Latrémouille-Viau D, Shi S, Guérin A, Wu EQ, Sadek I, Cao X. Stein EM, et al. Among authors: latremouille viau d. J Med Econ. 2021 Jan-Dec;24(1):234-243. doi: 10.1080/13696998.2021.1876714. J Med Econ. 2021. PMID: 33472483 Free article.

10

The risks and costs of multiple-generic substitution of topiramate.

Duh MS, Paradis PE, Latrémouille-Viau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MF, LeLorier J. Duh MS, et al. Among authors: latremouille viau d. Neurology. 2009 Jun 16;72(24):2122-9. doi: 10.1212/WNL.0b013e3181aa5300. Neurology. 2009. PMID: 19528520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results